科學專案合作夥伴
與日本抗體研究學會合作制定的會議議程
Accelerating Tomorrow's Antibody Therapeutics Today
The Summit of Antibody Science and Your Path to Commercial Success
Antibodies • Proteins • Bispecifics • Multispecifics • ADCs
What’s Waiting for You in Sunny San Diego
135+
World-Class Speaker Presentations
900+
Antibody Scientists & Executives
75+
Leading Industry Exhibitors
125+
Scientific Posters Highlighting Breakthrough Research
Where Antibody Breakthroughs Begin
Get an inside look at this year’s agenda - packed with world-class speakers and forward-thinking research across antibody engineering and therapeutic development.
Novel Bispecific and Multi-specific Antibodies
-
Explore advanced multispecific formats to overcome therapeutic limitations
-
Case studies on bispecific ADCs and conditional activation platforms
-
Engineering strategies for glycan targeting, avidity, and stability
Antibody Therapeutics in Emerging Disease Areas: Non-Oncology
-
Novel antibodies for fibrosis, cardiovascular disease, and CNS delivery
-
Innovative biologics targeting innate and adaptive immune pathways
-
Translating discoveries into therapies for complex non-oncology indications
Innovative Engineering for Cell Engagers
-
AI-driven design and next-gen T-cell engager platforms
-
Strategies to improve potency, selectivity, and safety in immunotherapy
-
Novel conditional engagers and dual-binding antibodies in cancer therapy
Antibody and Protein Therapeutics in Inflammation, Autoimmunity and Allergy
-
Breakthroughs in cell depletion strategies for autoimmune diseases
-
Next-gen cytokine blockers and trispecific antibodies for inflammation
-
Novel approaches to allergy treatment, from IgE cleavage to immune modulation
Emerging In Vitro Approaches to Antibody Discovery
-
Cutting-edge display technologies and high-throughput screening platforms
-
Computational and AI-driven antibody engineering for speed and precision
-
Case studies on de novo antibody design and rapid evolution systems
Engineering Innovative Formats and Scaffolds
-
Nanobody and knottin engineering for novel therapeutic applications
-
Advances in GPCR-targeting formats and allosteric modulators
-
Overcoming immunogenicity challenges with new scaffold architectures
Advanced In Vivo Antibody Discovery
-
Leveraging animal models and immune organoids for breakthrough discovery
-
In vivo screening approaches for CNS delivery and biodistribution
-
Strategies to accelerate discovery of antibodies against infectious diseases
Antibody Drug Conjugates - Novel Payloads and Engineering
-
Dual-payload ADCs for enhanced efficacy and resistance management
-
Site-specific conjugation techniques for stability and safety
-
Novel non-cytotoxic payloads and improved therapeutic index strategies
Engineering Considerations for Candidate Selection and Developability
-
Early risk mitigation for immunogenicity and chemical liabilities
-
ML-driven workflows for predictive developability optimization
-
High-throughput strategies for complex biologics like ADCs and bispecifics
Innovate, Invest, Succeed: The Business Landscape of Antibody Therapeutics
-
Investor perspectives on value creation and biotech funding trends
-
Lessons from successful preclinical-to-clinic transitions
-
Strategic insights for commercialization and portfolio optimization
Enhanced Efficacy Through Fc Engineering
-
Fc modifications to optimize effector function and immune activation
-
Site-specific conjugation and glycoengineering breakthroughs
-
Translating Fc innovations into next-gen therapeutics
Novel Extracellular Protein Degraders & Beyond
-
Cutting-edge eTPD platforms for transmembrane and extracellular targets
-
Novel bispecific degrader technologies and conjugate strategies
-
Expanding the druggable proteome beyond traditional antibody modalities
Discover the Keynote Speakers Driving Antibody Innovation
The Science. The Networking. The Moments.
Last year set the stage - 2025 will raise the bar. Watch the 2024 highlights, then join us this December in San Diego for the world’s leading antibody engineering event.
Ways to Attend
Join the Antibody Event of the Year in San Diego!
Get ready for 4 days of breakthrough science, powerful networking, and cutting-edge innovation at Antibody Engineering & Therapeutics US. This is your chance to:
✓ Access exclusive insights from 135+ world-renowned speakers sharing never-before-seen data and real-world case studies.
✓ Connect with 75+ leading solution providers driving the next wave of antibody engineering and therapeutic development.
✓ Explore the entire antibody landscape - from discovery and design to clinical development and commercialization.
Whether you’re passionate about bispecifics, ADCs, AI-driven discovery, or next-gen formats, this is where the future of antibody therapeutics takes shape.
Join us in sunny San Diego or tune in virtually from anywhere!
Showcase Your Research - Add a Poster Presentation
When you register for an in-person or digital Main Conference Pass (or Main Conference + Workshop Pass), you’ll have the exclusive opportunity to elevate your experience by adding a poster presentation for just $199.
This is your chance to:
✓ Showcase your research to leading scientists and industry innovators
✓ Spark meaningful discussions and gain valuable feedback
✓ Expand your professional visibility within the global antibody community
Don’t miss this opportunity to amplify your presence and make an impact!
Partner with the World’s Leading Antibody Event
Seize the opportunity to connect with key decision-makers and industry pioneers shaping the future of antibody therapeutics. As a sponsor of Antibody Engineering & Therapeutics US, your brand will be front and center at the industry’s most influential event, giving you:
✓ Unparalleled access to top biopharma leaders and innovators
✓ Opportunities to showcase your solutions to an engaged audience actively seeking new technologies and partnerships
✓ Direct connections that accelerate your business growth in the antibody and protein therapeutics market
Don’t miss your chance to position your brand at the forefront of antibody innovation.
關於抗體學會
抗體協會是支援從事抗體相關研究和開發的個人、組織的國際性非營利貿易協會。我們研究和分析生物製藥行業開發的標靶療法相關數據，並透過協會的網站、簡報、出版品發表成果及解說。該協會除了舉辦教育性質的網路研討會和研討會，同時也扮演著以抗體和 T 細胞受體的下一代定序之生成、使用、共享和標準化為焦點的 AIRR（適應性免疫受體庫）社群平台基地這樣的角色。此外，我們也與國際機構合作解決抗體界的重要議題。
我們的成員擔任Antibody Engineering & Therapeutics的科學顧問。會議的科學議程由我們的會議委員會設計。
